The Latest News
Exagen Completes $5.3M Financing to Develop New Diagnostics Products
Exagen Diagnostics Inc . said it raised $5.3 million to finance market expansion and development of near-term pipeline products. The commercial-stage company sells products for diagnosing and monitoring rheumatic diseases such as lupus.
Tullis Health Investors led the round. Other investors include Cottonwood Technology Fund, Epic Ventures , Mesa Verde Venture Partners and Sun Mountain Capital.
Exagen is based in Albuquerque, N.M., with a laboratory in Vista, Calif.